Antibody data
- Antibody Data
- Antigen structure
- References [11]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 26784-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- GCGR antibody
- Antibody type
- Polyclonal
- Description
- GCGR antibody (Cat. #26784-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references A Dual-compartment Scaffolding Role for Receptor for Activate C Kinase 1 in Hepatic Glucagon Signaling and Gluconeogenesis.
Irisin Alleviates Impaired Mitochondrial Fusion via Enhancing PKA/SIRT3/mTOR Pathway in Hepatic Steatosis.
A Dual-Compartment Scaffolding Role for RACK1 in Hepatic Glucagon Signaling and Gluconeogenesis.
Chlorogenic acid and ferulic acid in SMYAD alleviate diabetic cardiomyopathy by inhibiting cardiac lipotoxicity via GCGR/PPARα and GCGR/AMPK pathways.
Liver ALKBH5 regulates glucose and lipid homeostasis independently through GCGR and mTORC1 signaling.
Sex-Specific Differences in the Revascularization of Grafted Pancreatic Islets.
Glucagon receptor blockage inhibits β-cell dedifferentiation through FoxO1.
Pro-α-cell-derived β-cells contribute to β-cell neogenesis induced by antagonistic glucagon receptor antibody in type 2 diabetic mice.
Mof acetyltransferase inhibition ameliorates glucose intolerance and islet dysfunction of type 2 diabetes via targeting pancreatic α-cells.
Si-Miao-Yong-An decoction preserves cardiac function and regulates GLC/AMPK/NF-κB and GLC/PPARα/PGC-1α pathways in diabetic mice.
Tributyltin exposure disturbs hepatic glucose metabolism in male mice.
Lyu C, Yang L, Chen S
Cellular and molecular gastroenterology and hepatology 2026;20(2):101666
Cellular and molecular gastroenterology and hepatology 2026;20(2):101666
Irisin Alleviates Impaired Mitochondrial Fusion via Enhancing PKA/SIRT3/mTOR Pathway in Hepatic Steatosis.
Li J, Zhao Y, Wang Z, Ma A, Ni Y, Wu D, Zhou Y, Zhang N, Zhang L, Chang Y, Wang Q
Journal of gastroenterology and hepatology 2025 Jun;40(6):1616-1630
Journal of gastroenterology and hepatology 2025 Jun;40(6):1616-1630
A Dual-Compartment Scaffolding Role for RACK1 in Hepatic Glucagon Signaling and Gluconeogenesis.
Lyu C, Yang L, Chen S
bioRxiv : the preprint server for biology 2025 Jun 24;
bioRxiv : the preprint server for biology 2025 Jun 24;
Chlorogenic acid and ferulic acid in SMYAD alleviate diabetic cardiomyopathy by inhibiting cardiac lipotoxicity via GCGR/PPARα and GCGR/AMPK pathways.
Li L, Huang K, Wang D, Yang D, Gao K, Tang J, Wei X, Pu H, Yu J, Zhang D, Guo S
Phytomedicine : international journal of phytotherapy and phytopharmacology 2025 Jul 25;143:156906
Phytomedicine : international journal of phytotherapy and phytopharmacology 2025 Jul 25;143:156906
Liver ALKBH5 regulates glucose and lipid homeostasis independently through GCGR and mTORC1 signaling.
Ding K, Zhang Z, Han Z, Shi L, Li X, Liu Y, Li Z, Zhao C, Cui Y, Zhou L, Xu B, Zhou W, Zhao Y, Wang Z, Huang H, Xie L, Chen XW, Chen Z
Science (New York, N.Y.) 2025 Feb 28;387(6737):eadp4120
Science (New York, N.Y.) 2025 Feb 28;387(6737):eadp4120
Sex-Specific Differences in the Revascularization of Grafted Pancreatic Islets.
Wrublewsky S, Widmann AV, Bickelmann C, Rafacho A, Roma LP, Laschke MW, Ampofo E
Cells 2025 Aug 29;14(17)
Cells 2025 Aug 29;14(17)
Glucagon receptor blockage inhibits β-cell dedifferentiation through FoxO1.
Wang K, Cui X, Li F, Xia L, Wei T, Liu J, Fu W, Yang J, Hong T, Wei R
American journal of physiology. Endocrinology and metabolism 2023 Jan 1;324(1):E97-E113
American journal of physiology. Endocrinology and metabolism 2023 Jan 1;324(1):E97-E113
Pro-α-cell-derived β-cells contribute to β-cell neogenesis induced by antagonistic glucagon receptor antibody in type 2 diabetic mice.
Cui X, Feng J, Wei T, Gu L, Wang D, Lang S, Yang K, Yang J, Yan H, Wei R, Hong T
iScience 2022 Jul 15;25(7):104567
iScience 2022 Jul 15;25(7):104567
Mof acetyltransferase inhibition ameliorates glucose intolerance and islet dysfunction of type 2 diabetes via targeting pancreatic α-cells.
Guo X, Cui C, Song J, He Q, Zang N, Hu H, Wang X, Li D, Wang C, Hou X, Li X, Liang K, Yan F, Chen L
Molecular and cellular endocrinology 2021 Nov 1;537:111425
Molecular and cellular endocrinology 2021 Nov 1;537:111425
Si-Miao-Yong-An decoction preserves cardiac function and regulates GLC/AMPK/NF-κB and GLC/PPARα/PGC-1α pathways in diabetic mice.
Li L, Chen X, Su C, Wang Q, Li R, Jiao W, Luo H, Tian Y, Tang J, Li X, Liu B, Wang W, Zhang D, Guo S
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2020 Dec;132:110817
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2020 Dec;132:110817
Tributyltin exposure disturbs hepatic glucose metabolism in male mice.
Xu J, Ou K, Chen C, Li B, Guo J, Zuo Z, Wang C
Toxicology 2019 Sep 1;425:152242
Toxicology 2019 Sep 1;425:152242
No comments: Submit comment
No validations: Submit validation data